Bed Bath With Auditory Hypnosis on ICU Patients
Launched by BANU TERZI · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how bed baths combined with auditory hypnosis might help patients in intensive care units (ICUs). The researchers want to see if using calming sounds or music during bed baths can improve patients' comfort and help keep their vital signs stable. They believe that this approach could reduce stress and make the bed bathing experience better for patients, who often have limited movement due to medical equipment.
To participate in the study, patients must be over 18 years old and have specific medical conditions that allow them to be safely included. For example, they should be able to respond to basic questions and have been in the ICU for at least 24 hours. Participants will receive a bed bath with auditory suggestions or a routine bed bath, and their comfort and vital signs will be monitored before, immediately after, and 30 minutes after the bath. This trial aims to gather valuable information that could improve care for critically ill patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years of age
- • Glasgow Coma Scale score: 8 and above
- • Richmond Agitation-Sedation Scale (RASS) score between +2 and -3
- • APACHE II score \<10 points
- • Stayed in the ICU for at least 24 hours
- • Continues breathing with invasive mechanical ventilation support device
- • Not receiving antihypertensive treatment
- • Not taking inotropic drugs that directly affect vital signs (esmolol, noradrenaline, dopamine, adrenaline, dopamine, nitrate, etc.)
- • No wounds/injuries that would prevent bed bathing
- • There is no harm in moving it
- • Routine blood gas values (no extra blood gas sample will be taken for this study)
- Exclusion Criteria:
- • Glasgow Coma Scale score: Under 8
- • Richmond Agitation-Sedation Scale (RASS) score of +3 and above, -4 and below
- • APACHE II score \>10 points
- • Stayed in ICU for less than 24 hours
- • Referred to another ICU or clinic during the collection of research data
- • Intubated in less than 24 hours
- • Treatment protocol changed (hypertension and inotrope etc. drugs started)
- • Disturbed physiological parameters during bed bathing
- • Restricted mobility
- • No request for blood gas collection/no blood gas value
- • Patients who exit during the study period will be excluded from the study.
About Banu Terzi
Banu Terzi is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous and ethical study designs. With a commitment to enhancing patient care, the organization collaborates with leading healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Banu Terzi emphasizes transparency, compliance, and collaboration, ensuring that all trials are conducted with the highest standards of integrity and scientific rigor. Through its strategic partnerships and commitment to patient safety, Banu Terzi aims to contribute significantly to the development of new therapies and improve health outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antalya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported